Year |
Citation |
Score |
2023 |
Booth BJ, Nourreddine S, Katrekar D, Savva Y, Bose D, Long TJ, Huss DJ, Mali P. RNA Editing: Expanding the Potential of RNA Therapeutics. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36620962 DOI: 10.1016/j.ymthe.2023.01.005 |
0.491 |
|
2022 |
Houles T, Lavoie G, Nourreddine S, Cheung W, Vaillancourt-Jean É, Guérin CM, Bouttier M, Grondin B, Lin S, Saba-El-Leil MK, Angers S, Meloche S, Roux PP. CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma. Nature Communications. 13: 6457. PMID 36309522 DOI: 10.1038/s41467-022-34179-8 |
0.522 |
|
2022 |
Vadnjal N, Nourreddine S, Lavoie G, Serres M, Roux PP, Paluch EK. Proteomic analysis of the actin cortex in interphase and mitosis. Journal of Cell Science. PMID 35892282 DOI: 10.1242/jcs.259993 |
0.469 |
|
2020 |
Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J, Saba-El-Leil MK, Papadopoli D, Lin S, Hart T, Macleod G, Topisirovic I, Gaboury L, Fahrni CJ, Schramek D, et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nature Communications. 11: 3701. PMID 32709883 DOI: 10.1038/S41467-020-17549-Y |
0.507 |
|
2020 |
Nourreddine S, Lavoie G, Paradis J, Ben El Kadhi K, Méant A, Aubert L, Grondin B, Gendron P, Chabot B, Bouvier M, Carreno S, Roux PP. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay. Cell Reports. 31: 107660. PMID 32433969 DOI: 10.1016/J.Celrep.2020.107660 |
0.501 |
|
2019 |
Meant A, Gao B, Lavoie G, Nourreddine S, Jung F, Aubert L, Tcherkezian J, Gingras AC, Roux PP. Proteomic analysis reveals a role for RSK in p120-catenin phosphorylation and melanoma cell-cell adhesion. Molecular & Cellular Proteomics : McP. PMID 31678930 DOI: 10.1074/Mcp.Ra119.001811 |
0.527 |
|
2016 |
Gerby B, Veiga DF, Krosl J, Nourreddine S, Ouellette J, Haman A, Lavoie G, Fares I, Tremblay M, Litalien V, Ottoni E, Kosic M, Geoffrion D, Ryan J, Maddox PS, et al. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells. The Journal of Clinical Investigation. PMID 27797342 DOI: 10.1172/Jci86489 |
0.497 |
|
Show low-probability matches. |